Central Nervous System Therapeutics Market Growth to 2034
The global Central Nervous System Therapeutics Market is entering an important period of pharmaceutical development as healthcare systems respond to increasing neurological and psychiatric treatment needs. Advances in neuroscience, personalized medicine, and targeted drug delivery are creating new possibilities for managing conditions affecting the brain and spinal cord. According to Dimension Market Research, the global market is projected to reach USD 163.8 billion in 2025 and increase to USD 412.1 billion by 2034 , representing a compound annual growth rate (CAGR) of 10.8% from 2025 to 2034 . The expanding burden of Alzheimer's disease, Parkinson's disease, epilepsy, depression, and other CNS disorders is encouraging pharmaceutical manufacturers to develop more effective treatments. Meanwhile, biotechnology investment and improvements in disease diagnosis are influencing research priorities and long-term commercial opportunities. What Is the Central Nervous System Therapeu...